Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of the motor system in adults that occurs in sporadic, familial, and Western Pacific forms. Involvement of non‐motor pathways has been increasingly recognized, both clinically and pathologically. Although the usual course is relentlessly progressive with death in half the cases within three years from onset, it can sometimes be protracted. Degeneration and loss of large motor neurons in the cerebral cortex, brainstem, and cervical and lumbar spinal cord are characteristic. Marked reduction in the number of large myelinated fibers is notable in the cervical and lumbar ventral roots. Peripheral nerves show reduced numbers of large myelinated fibers, acute axonal degeneration at all levels, and distal axonal atrophy. Motor end‐plates reveal small or absent nerve terminals. Subclinical non–motor system involvement includes neuronal loss in Clarke's nucleus and dorsal root ganglia, degeneration of non‐motor tracts in the spinal cord, loss of receptors in the dorsal horns of the spinal cord, and myelinated fiber loss with segmental demyelination in sensory and mixed nerves. The serious implications of the diagnosis of ALS make it mandatory to exclude similar potentially treatable disorders. Management should be multidisciplinary, and discussions with the patient and family members should be frank and frequent. Discussions about ventilatory support should take place early in the disease so that death from respiratory failure can be prevented, when that is desired, and conversely to obviate the discontent and anger that accompany involuntary life on a ventilator.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of clinical neurology
Servit, Z. (1975) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(75)90177-7 · Cited by 1,640
Chronic Inflammatory Polyradiculoneuropathy
Millichap, J. G. (1997) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-11-12-6 · Cited by 822
Adams, R. D. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61506-7 · Cited by 600
The central nervous system in motor neurone disease
Brownell, B., Oppenheimer, D. R., & Hughes, J. T. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.3.338 · Cited by 483
Experimental and Clinical Neurotoxicology
ROSENBERG, R. N. (1981) · Neurology · doi:10.1212/wnl.31.3.369-a · Cited by 409
HUDSON, A. J. (1981) · Brain · doi:10.1093/brain/104.2.217 · Cited by 369
Proximal axonal enlargement in motor neuron disease
Carpenter, S. (1968) · Neurology · doi:10.1212/wnl.18.9.841 · Cited by 358
Rowland, L. P. (1982) · PubMed · Cited by 348
AMYOTROPHIC LATERAL SCLEROSIS: A Clinicoanatomic Study of Fifty-Three Cases
LAWYER, T. (1953) · A.M.A. Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1953.02320260029002 · Cited by 281
Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis
Bradley, W. G., Good, P., Rasool, C. G., & Adelman, L. S. (1983) · Annals of Neurology · doi:10.1002/ana.410140304 · Cited by 218
Self-citation
Cited by
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H.-X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,477
Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis
Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
Bosco, D. A., Morfini, G., Karabacak, N. M., Song, Y., Gros-Louis, F., Pasinelli, P., Goolsby, H., Fontaine, B. A., Lemay, N., McKenna-Yasek, D., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2660 · Cited by 686
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
Pestronk, A., Cornblath, D. R., Ilyas, A. A., Baba, H., Quarles, R. H., Griffin, J. W., Alderson, K., & Adams, R. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240113 · Cited by 609
Neurologic Sequelae of Domoic Acid Intoxication Due to the Ingestion of Contaminated Mussels
Teitelbaum, J. S., Zatorre, R. J., Carpenter, S., Gendron, D., Evans, A. C., Gjedde, A., & Cashman, N. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006213222505 · Cited by 555
(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 499
Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Dal Canto, M. C., & Gurney, M. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00063-v · Cited by 435
Biological and physiological role of reactive oxygen species - the good, the bad and the ugly
Zuo, L., Zhou, T., Pannell, B. K., Ziegler, A. C., & Best, T. M. (2015) · Acta Physiologica · doi:10.1111/apha.12515 · Cited by 427
Management guidelines for motor neurone disease patients on non-invasive ventilation at home
Eng, D. (2006) · Palliative Medicine · doi:10.1191/0269216306pm1113oa · Cited by 340
ESPOSITO, E., ROTILIO, D., DIMATTEO, V, DIGIULIO, C., CACCHIO, M., & ALGERI, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 326
Andersen, P. M., Nilsson, P., Ala-Hurula, V., Keränen, M.-L., Tarvainen, I., Haltia, T., Nilsson, L., Binzer, M., Forsgren, L., & Marklund, S. L. (1995) · Nature Genetics · doi:10.1038/ng0595-61 · Cited by 322
Abnormal glutamate metabolism in amyotrophic lateral sclerosis
Plaitakis, A., & Caroscio, J. T. (1987) · Annals of Neurology · doi:10.1002/ana.410220503 · Cited by 305
Oestreicher, A. B., De Graan, P. N. E., Gispen, W. H., Verhaagen, J., & Schrama, L. H. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00043-9 · Cited by 290
Genetics of familial and sporadic amyotrophic lateral sclerosis
Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.004 · Cited by 255
Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis
Kühnlein, P., Gdynia, H.-J., Sperfeld, A.-D., Lindner-Pfleghar, B., Ludolph, A. C., Prosiegel, M., & Riecker, A. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0853 · Cited by 252
Survival in Amyotrophic Lateral Sclerosis: The Role of Psychological Factors
McDonald, E. R. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540130027010 · Cited by 193
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
Tesla, R., Wolf, H. P., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P., McDaniel, L., Knobbe, W., Burket, A., Tran, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213960109 · Cited by 129
Amyotrophic Lateral Sclerosis: Current and Future Treatment Strategies
Festoff, B. W. (1996) · Drugs · doi:10.2165/00003495-199651010-00004 · Cited by 35
Metadata
- Authors
- Tandan, R., & Bradley, W. G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1985-09
- Volume
- 18
- Issue
- 3
- Pages
- 271-280
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1970603050
- Cited by
- 365
- References
- 65
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.